Ann: Dimerix to present at Melbourne Twilight Investor Briefing, page-8

  1. 325 Posts.
    lightbulb Created with Sketch. 102
    Great investor briefing, and the best part is, even this far into phase 3 we still have no
    Side effects, what a blessing for the patients and a huge bonus for Dimerix
    to still be able to say, our treatment for FSGS has no SIDE EFFECTS !
    Not every company trying to treat FSGS can say this, but we sure as heck can.

    I think one resident pest will get the message when he reads this lol
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
47.0¢
Change
-0.005(1.05%)
Mkt cap ! $282.0M
Open High Low Value Volume
47.0¢ 49.3¢ 46.5¢ $1.188M 2.509M

Buyers (Bids)

No. Vol. Price($)
3 28330 47.0¢
 

Sellers (Offers)

Price($) Vol. No.
49.0¢ 48233 4
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.